Ethiopia has been formally recognized by the World Health Organization (WHO) for achieving Maturity Level 3 (ML3), placing it among nine African countries with this status in WHO's global classification of national regulatory authorities .
This milestone reflects the Ethiopian Food and Drug Authority's (EFDA) commitment to ensuring that medicines and imported vaccines available in the country meet international standards of quality, safety and efficacy. The designation follows a comprehensive WHO assessment using its Global Benchmarking Tool , which evaluates regulatory systems against more than 250 indicators.
Maturity Level 3 is defined by WHO as a stable, well-functioning, and integrated regulatory system. Countries that reach this level are recognized for their capacity to authorize medical products, conduct market surveillance and monitor safety events effectively. Maturity Level 4, the highest level, signifies an advanced regulatory system committed to ongoing improvement.
Ethiopia now joins Egypt, Ghana, Nigeria, South Africa, Tanzania, Zimbabwe, Senegal and Rwanda in reaching ML3 on the continent.
"Ethiopia's achievement is a landmark moment not only for the country but for Africa as a whole," said Dr Mohamed Yakub Janabi, WHO Regional Director for Africa. "A strong regulatory system means patients can trust that the medicines they take are safe, effective and of assured quality. This is a foundation for universal health coverage and healthier futures."
The benchmarking process in Ethiopia, completed in September 2025, was supported by the WHO Regional Office for Africa and the WHO Country Office in Addis Ababa.
The WHO global benchmarking process is part of WHO's programme to strengthen regulatory systems , evaluating core functions such as product authorization, market surveillance, and adverse event detection. Countries that reach ML3 and ML4 may also qualify as WHO-listed Authorities following further performance evaluations, enabling them to play a greater role in guiding global regulatory standards.
"Effective regulation saves lives," said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. "By reaching Maturity Level 3, Ethiopia has demonstrated leadership and commitment to protecting its population, strengthening its health system, and contributing to regional and global efforts to improve access to quality-assured medical products."
Effective regulation of medical products is essential for all health systems, ensuring access to quality, safe, and effective medicines, vaccines and other medical products. Strong regulatory authorities perform critical functions like rapid product authorization and robust safety monitoring, contributing to better health outcomes.
Ethiopia's achievement is not only a national success story but also a beacon for the region, showing that with sustained commitment, Africa can shape the future of health products regulation and ensure that safe, high-quality medical products are within reach for every community.
